Clinical trial evaluating mixed COVID-19 vaccine schedules begins
Most kids’ ear infections can be treated with antibiotics, study finds. But parents may opt for tubes.
2 June 2021Study finds major anti-inflammatory immune activity that favors oral cancer tumors
2 June 2021Clinical trial evaluating mixed COVID-19 vaccine schedules begins
The National Institutes of Health has started a Phase 1/2 clinical trial in which adult volunteers who have been fully vaccinated against COVID-19 will receive booster doses of different COVID-19 vaccines to determine the safety and immunogenicity of mixed boosted regimens. The National Institute of Allergy and Infectious Diseases (NIAID), part of NIH, is leading and funding the study through the Infectious Diseases Clinical Research Consortium, a clinical trials network that encompasses the Institute’s long-standing Vaccine and Treatment Evaluation Units (VTEUs).
